Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1093-1097

  Martin, Claude ^a   Cotin, Agnès ^b   Giraud, Annick ^a   Beccani Argème, Mireille ^a   Alliot, Pierre ^a   Mallet, Marie Noëlle ^b   Argéme, Maxime ^a  

^a HÔPITAL NORD   (France)

^b Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; SULBACTAM; SULTAMICILLIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERICIDAL ACTIVITY; BOLUS INJECTION; CLINICAL ARTICLE; COLORECTAL SURGERY; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; DRUG MIXTURE; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; WOUND INFECTION;

EID: 0031979980     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1093     Document Type: Article

References (23)

1. Aldridge, K. E., D. Ashcraft, and K. A. Bowman. 1997. Comparative in vitro activities of trovafloxacin (CP 99, 219) and other antimicrobials against clinically significant anaerobes. Antimicrob. Agents Chemother. 41:484-487.
2. Alexov, M., P. D. Lister, and C. C. Sanders. 1996. Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactions. Antimicrob. Agents Chemother. 40:2468-2477.
3. Appelbaum, P. C., M. R. Jacobs, S. K. Spangler, and S. Yamabe. 1986. Comparative activity of β-lactamase inhibitors YTR 30, clavulanate, and sulbactam combined with β-lactams against β-lactamase-producing anaerobes. Antimicrob. Agents Chemother. 30:789-791.
4. Baum, M. L., D. S. Anisch, T. C. Chalmers, M. S. Sacks, H. Smith, and R. M. Fagerstrom. 1981. A survey of clinical trials of antibiotic prophylaxis in colon surgery. Evidence against further use of no treatment controls. N. Engl. J. Med. 305:795-799.
5. Bawdon, R. E., and P. O. Madsen. 1986. High-pressure liquid chromatography assay of sulbactam in plasma, urine, and tissues. Antimicrob. Agents Chemother. 30:231-233.
6. Benko, A. S., D. M. Cappelletty, J. A. Kruse, and M. J. Rybak. 1996. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections. Antimicrob. Agents Chemother. 40:691-695.
7. Bergamini, T. M., and M. C. Polk. 1989. The importance of tissue antibiotic activity in the prevention of operative wound infection. J. Antimicrob. Chemother. 23:301-313.
8. Brown, R. M., R. Wise, J. M. Andrews, and J. Hancox. 1982. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration. Antimicrob. Agents Chemother. 21: 565-567.
9. Burke, J. F. 1961. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50:161-168.
10. De la Hunt, H. N., S. J. Karran, and M. Chir. 1986. Sulbactam/ampicillin compared with cefoxitin for chemoprophylaxis in elective colorectal surgery. Dis. Colon Rectum 29:157-159.
11. Foster, M. C., L. Kapila, D. L. Morris, and R. C. B. Slack. 1986. A randomized comparative study of sulbactam plus ampicillin VS metronidazole plus cefotaxime in the management of acute appendicitis in children. Rev. Infect. Dis. 8(Suppl. 5):634-638.
12. Foulds, G., J. P. Stankewich, D. C. Marshall, M. M. O'Brien, and S. L. Hayes. 1983. Pharmacokinetics of sulbactam in humans. Antimicrob. Agents Chemother. 23:692-699.
13. Houang, E., N. Colley, and M. Chapman. 1985. Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum. Antimicrob. Agents Chemother. 28:165-166.
14. Kager, L., A. S. Malmborg, S. Sjöstedt, and C. E. Nord. 1983. Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonie microflora in patients undergoing colorectal surgery. Eur. J. Clin. Microbiol. 2:559-563.
15. Kaiser, A. B. 1986. Antimicrobial prophylaxis in surgery. N. Engl. J. Med. 315:1129-1138.
16. Kinzig, M., F. Sörgel, B. Brismar, and C. E. Nord. 1992. Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery. Antimicrob. Agents Chemother. 36:1997-2004.
17. Martin, C., M. N. Mallet, B. Sastre, X. Viviand, A. Martin, P. De Micco, and F. Gouin. 1995. Comparison of concentrations of two doses of clavulanic acid (200 and 400 milligrams) administered with amoxicillin (2,000 milligrams) in tissues of patients undergoing colorectal surgery. Antimicrob. Agents Chemother. 39:94-98.
18. Martin, C., C. Portet, D. Lambert, B. Bruguerolle, B. Sastre, P. De Micco, and F. Gouin. 1992. Pharmacokinetics and tissue penetration of single dose cefotetan used for antimicrobial prophylaxis in patients undergoing colorectal surgery. Antimicrob. Agents Chemother. 36:1115-1118.
19. Martin, C., B. Sastre, M. N. Mallet, B. Bruguerolle, J. P. Brun, and F. Gouin. 1991. Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery. Antimicrob. Agents Chemother. 35:2602-2605.
20. Medeiros, A. A. 1984. β-Lactamases. Br. Med. Bul. 40:18-27.
21. Rogers, H. J., I. D. Bradbrook, P. J. Morisson, R. G. Spector, D. A. Cox, and I. J. Lees. 1983. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography. J. Antimicrob. Chemother. 11:195-203.
22. Stone, H. H. 1984. Basic principles in the use of prophylactic antibiotics. J. Antimicrob. Chemother. 14(Suppl. B):33-37.
23. Wildfeuer, A., U. Schwiersch, K. Engel, E. Castell, A. Schilling, J. Potempa, and H. Lenders. 1988. Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Arzneim.-Forsch./Drug. Res. 38(Suppl. 2):1640-1643.